Clinical Trial Update: Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using mesalamine to prevent colorectal cancer in Lynch syndrome; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Lynch Syndrome

Drugs mentioned

• Mesalamine (Mesalamine)

Snippet

Sponsor: Ann-Sofie Backman | Conditions: Lynch Syndrome, Colon Cancer | Phase 2 | Status: RECRUITING